Aberrant promoter DNA methylation inhibits bone morphogenetic protein 2 expression and contributes to drug resistance in breast cancer

By Du Min   Su XiaoMei   Zhang Tao   Xing YongJun  

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-08 ,pp. : 1051-1055

Spandidos Publications

Access to resources Recommend Favorite

Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma

By          

Molecular Medicine Reports, Vol. 7, Iss. 3, 2013-01 ,pp. : 1055-1061

Spandidos Publications

Access to resources Recommend Favorite

Bone diesease in multiple myeloma

By Hjertner Øyvind   Standal Therese   Børset Magne   Sundan Anders   Waage Anders  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 431-441

Humana Press, Inc

Access to resources Recommend Favorite

The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma

By            

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 551-555

Spandidos Publications

Access to resources Recommend Favorite

APC promoter methylation and protein expression in hepatocellular carcinoma

By Csepregi Antal   Röcken Christoph   Hoffmann Juliane   Gu Ping   Saliger Stephan   Müller Oliver   Schneider-Stock Regine   Kutzner Nadine   Roessner Albert   Malfertheiner Peter   Ebert Matthias  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 579-589

Springer Publishing Company

Access to resources Recommend Favorite